ArticleAnnals of nuclear medicine2026
Baseline
Article in Annals of nuclear medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo evaluate whether baseline
methodsThis retrospective single-center study included 48 patients with histopathologically confirmed LARC who underwent baseline
resultsSixteen patients had Ryan 3 poor pathological response and 32 had Ryan 0-2 response. MTV, TLG, HI, and clinical/radiological T stage were significantly higher in Ryan 3 patients, whereas age, sex, CEA, clinical/radiological N stage, SUVmax, and SUVmean did not differ significantly between response groups. SUVmax and SUVmean showed no significant discriminatory value. HI showed the numerically highest AUC (0.760; bootstrapped 95% CI, 0.586-0.899), with predictive performance comparable to MTV (AUC 0.749) and TLG (AUC 0.748). In restricted T-stage-adjusted models, HI, MTV, and TLG remained independently associated with Ryan 3 poor response. Bootstrap optimism-corrected AUCs were 0.847, 0.842, and 0.813 for HI + T stage, MTV + T stage, and TLG + T stage models, respectively.
conclusionBaseline
Indexed as
Identifiers
42627579What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.